The current ENTBF market cap is 1.04M. The company's latest EPS is CAD -0.0359 and P/E is -3.34.
Year End 30 November 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Total Revenue | 0 | 22k | 214k | 250k | 0 |
Operating Income | -905k | -7.44M | -2.82M | 131k | -333k |
Net Income | -4.38M | -8.89M | -8.52M | -300k | -318k |
Year End 30 November 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Total Assets | 4.47M | 9.98M | 769k | 401k | 185k |
Total Liabilities | 728k | 928k | 154k | 85k | 40k |
Total Equity | 3.75M | 9.05M | 615k | 316k | 145k |
Year End 30 November 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Operating | -2.84M | -5.62M | -1.95M | -359k | -356k |
Investing | 1.08M | -99k | 585k | 24k | N/A |
Financing | 4.43M | 4.98M | N/A | N/A | 147k |
Market Cap | 1.04M |
Price to Earnings Ratio | -3.34 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 7.79 |
Price to Book Ratio | 7.33 |
Dividend Yield | - |
Shares Outstanding | 8.86M |
Average Volume (1 week) | 1.17k |
Average Volume (1 Month) | 2.1k |
52 Week Change | -30.43% |
52 Week High | 0.288 |
52 Week Low | 0.0225 |
Spread (Intraday) | 0.27 (99.63%) |
Company Name | Entheon Biomedical Corporation (QB) |
Address |
10th floor, 595 howe street vancouver, british columbia V6C 2T5 |
Website | https://www.entheonbiomedical.com |
Industry | miscellaneous metal ores,nec (1099) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions